title: [Hormone substitution following transcervical endometrial ablation].
abstract: The transcervical endometrium ablation is more and more used for the treatment of therapy refractory bleeding disorders. Since in 70% of the patients, even with a postoperative amenorrhoea, a residual endometrium can be found a hormone replacement therapy should in any case include a sequential or continuous application of progestagen. For the prevention of a hematometra by using a hormone replacement therapy the cervix should be spared during endometrium ablation. With recurrent therapy-refractory bleeding disorders during hormone replacement therapy an indication for endometrium ablation can also be given. In these patients a postoperative amenorrhoea can be reached by a continuous hormone replacement therapy.
authors.affiliation: Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Ernst-Moritz-Arndt-Universität Greifswald.
authors.forename: T
authors.initials: T
authors.lastname: Römer
mesh_terms: D004717:Endometrium / Q000601:surgery*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008796:Metrorrhagia / Q000601:surgery*; D017698:Postmenopause; D011183:Postoperative Complications / Q000517:prevention & control